MarketPeel
Insider Trading Intelligence
Pricing
…
DA

Deborah M. Autor

HIMS
CHIEF POLICY OFFICER · HIMS & HERS HEALTH, INC. · CIK 0001884671
FILING MIX · LIFETIME51%/49%
BUYS
18
SELLS
17
TOTAL VALUE
$2.04M
COMPANIES
2
ACTIVE SINCE
Jul 2022
HOLDINGS NOW
142,621
AVG SELL PX
$13.95
TRADE KIND
SHOWING 35 / 35
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
6 backtested trades · 8 horizons · 9 pending
Forward-return performance of every backtestable P/S trade by Deborah M. Autor, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d6+83.33%-3.11%+0.80%-3.91%-3.88%—
14d6+50.00%-1.46%+0.85%-1.72%-1.35%—
30d6+66.67%-1.32%+1.47%-2.79%-5.38%—
60d6(1 pending)+20.00%-5.54%+3.73%-9.27%+0.96%—
90d6(1 pending)+60.00%-1.75%+2.86%-4.61%-9.04%—
180d6(1 pending)+60.00%+5.08%+7.32%-2.24%-11.32%—
1y6(2 pending)+0.00%+27.52%+12.64%+14.88%+14.91%—
2y6(4 pending)+0.00%+75.83%+42.09%+33.74%+33.74%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
HIMS · 48,961 shares · as of Jun 15, 2026
0131,678263,356395,033526,71120252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 18 buys / 17 sellsCOVERAGE · 16 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
HIMS
HIMS & HERS HEALTH, INC.
SALE
Chief Policy Officer
15,396$30.17$464.5K48,961Jun 15, 2026Jun 17, 2026 ↗View →
HIMS
HIMS & HERS HEALTH, INC.
PURCHASE
Chief Policy Officer
32,919——64,357Jun 15, 2026Jun 17, 2026 ↗View →
HIMS
HIMS & HERS HEALTH, INC.
SALE
Chief Policy Officer
32,919——460,873Jun 15, 2026Jun 17, 2026 ↗View →
HIMS
HIMS & HERS HEALTH, INC.
SALE
Chief Policy Officer
3,656——0Jun 11, 2026Jun 15, 2026 ↗View →
HIMS
HIMS & HERS HEALTH, INC.
PURCHASE
Chief Policy Officer
3,656——31,438Jun 11, 2026Jun 15, 2026 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
34,819$12.94$450.6K93,660May 11, 2026May 12, 2026 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
34,819——0May 7, 2026May 8, 2026 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
34,819——128,479May 7, 2026May 8, 2026 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
19,824——19,824May 6, 2026May 8, 2026 ↗View →
HIMS
HIMS & HERS HEALTH, INC.
SALE
Chief Policy Officer
11,312$24.77$280.2K27,782Mar 13, 2026Mar 17, 2026 ↗View →
HIMS
HIMS & HERS HEALTH, INC.
SALE
Chief Policy Officer
32,919——493,792Mar 13, 2026Mar 17, 2026 ↗View →
HIMS
HIMS & HERS HEALTH, INC.
PURCHASE
Chief Policy Officer
32,919——39,094Mar 13, 2026Mar 17, 2026 ↗View →
HIMS
HIMS & HERS HEALTH, INC.
PURCHASEGRANT
Stock grant
526,711——526,711Mar 11, 2026Mar 13, 2026 ↗View →
HIMS
HIMS & HERS HEALTH, INC.
SALE10b5-1
10b5-1 plan
7,054$36.71$259.0K6,175Dec 17, 2025Dec 18, 2025 ↗View →
HIMS
HIMS & HERS HEALTH, INC.
PURCHASE
Chief Policy Officer
7,054——13,229Dec 15, 2025Dec 16, 2025 ↗View →
HIMS
HIMS & HERS HEALTH, INC.
SALE
Chief Policy Officer
7,054——14,110Dec 15, 2025Dec 16, 2025 ↗View →
HIMS
HIMS & HERS HEALTH, INC.
PURCHASEGRANT
Stock grant
3,656——3,656Aug 6, 2025Aug 8, 2025 ↗View →
HIMS
HIMS & HERS HEALTH, INC.
PURCHASE
6,175——6,175Jun 12, 2025Jun 16, 2025 ↗View →
HIMS
HIMS & HERS HEALTH, INC.
SALE
6,175——0Jun 12, 2025Jun 16, 2025 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
34,819——34,819May 6, 2025May 8, 2025 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
40,258——93,660May 5, 2025May 8, 2025 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
40,258——0May 5, 2025May 8, 2025 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
33,229$8.34$277.1K53,402Nov 22, 2024Nov 25, 2024 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
6,771$8.41$56.9K86,631Nov 21, 2024Nov 25, 2024 ↗View →
HIMS
HIMS & HERS HEALTH, INC.
PURCHASEGRANT
Stock grant
21,164——21,164Nov 15, 2024Nov 19, 2024 ↗View →
HIMS
HIMS & HERS HEALTH, INC.
PURCHASEGRANT
Stock grant
6,175——6,175Nov 15, 2024Nov 19, 2024 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
23,447$6.73$157.7K93,402May 17, 2024May 20, 2024 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
14,553$6.76$98.4K116,849May 16, 2024May 20, 2024 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
76,453——131,402May 10, 2024May 14, 2024 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
76,453——0May 10, 2024May 14, 2024 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
40,258——40,258May 2, 2024May 6, 2024 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASE
54,949——54,949Jul 30, 2023Aug 1, 2023 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
SALE
54,949——0Jul 30, 2023Aug 1, 2023 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
76,453——76,453May 9, 2023May 11, 2023 ↗View →
AMRX
AMNEAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
54,949——54,949Jul 29, 2022Aug 2, 2022 ↗View →
Other insiders · HIMS
Loading peer insiders…
About this filer
CIK 0001884671
ROLE
Chief Policy Officer
PRIMARY
HIMS
COMPANIES
2
ACTIVE SINCE
Jul 2022
MARKETPEEL · /INSIDER/0001884671DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback